AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹2,906 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr | ₹0.25 Cr |
What is the latest Total Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹2,906 Cr |
| Mar2024 | ₹2,582 Cr |
| Mar2023 | ₹2,244 Cr |
| Mar2022 | ₹2,040 Cr |
| Mar2021 | ₹0.25 Cr |
How is Total Liabilities of AARTI PHARMALABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,906 Cr | 12.56 | |
| Mar2024 | ₹2,582 Cr | 15.07 | |
| Mar2023 | ₹2,244 Cr | 10.01 | |
| Mar2022 | ₹2,040 Cr | 815,860.00 | |
| Mar2021 | ₹0.25 Cr | - | |
Compare Total Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹5,887.8 Cr | 6.6% | -8.1% | -13.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,495.0 Cr | -5.7% | -3.3% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹154,244.0 Cr | -3.1% | -9.3% | 0% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,634.0 Cr | -6.1% | -8.3% | 23.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,594.0 Cr | -5.1% | -6% | 4.8% | Stock Analytics | |
| CIPLA | ₹97,022.8 Cr | -3.3% | -11.2% | -19.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 6.6% |
-8.1% |
-13.3% |
| SENSEX | -1.6% |
-8.8% |
-4.1% |
You may also like the below Video Courses